drugset / Trial / NCT00321113

Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys

NCT00321113

Phase 3 Completed 142 enrolled Astellas Pharma Inc
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to explore the safety and efficacy of two different immunosuppressive regimens (sequential tacrolimus/mycophenolate mofetil \[MMF\] plus steroids versus tacrolimus plus MMF, following induction with daclizumab) in recipients of marginal donor kidneys.

Timeline

Start
2004-09
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Mycophenolate Mofetil Small molecule Oral
Subject Prednisone Other / unclassified Oral
Subject Tacrolimus Small molecule Oral

Indications

No indication recorded.